To view this email as a web page, click here.
March 29, 2018
 
FDA approves a new, more powerful psoriasis drug
"As we move toward finding a cure for psoriasis, what we are looking for are high performance drugs that provide durable response in between treatments and that lend themselves to patient compliance," says Dr. George Martin. Learn more.
 
Neurologic changes that stem from biologic therapy
Physicians should be aware of the warning signs that a biologic agent could be to blame when patients experience subacute or rapidly progressive neurologic changes, researchers say. Learn more.
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.